Home LiteratureArticle Details
PMID: 22473328 Published · ppublish English Journal Article Review

Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium.

Metallomics : integrated biometal science ·Vol. 4 ·No. 7 ·2012-07-00 ·Pages 619-27

Chervona Y, Arita A, Costa M

Abstract

Carcinogenic metals, such as nickel, arsenic, and chromium, are widespread environmental and occupational pollutants. Chronic exposure to these metals has been connected with increased risks of numerous cancers and as well as non-carcinogenic health outcomes, including cardiovascular disease, neurologic deficits, neuro-developmental deficits in childhood, and hypertension. However, currently the specific molecular targets for metal toxicity and carcinogenicity are not fully understood. Here, we propose that the iron- and 2-oxoglutarate-dependent dioxygenase family enzymes, as well as, other histone modifying enzymes are important intracellular targets that mediate the toxicity and carcinogenicity of nickel, and maybe potential targets in chromium and arsenic induced carcinogenesis. Our data demonstrate that all three metals are capable of inducing post-translational histone modifications and affecting the enzymes that modulate them (i.e. the iron- and 2-oxoglutarate-dependent dioxygenase family, including HIF-prolyl hydroxylase PHD2, histone demethylase JHDM2A/JMJD1A, and DNA repair enzymes ABH3 and ABH2, and histone methyltransferases, G9a). Given the effects that these metals can exert on the epigenome, future studies of their involvement in histone modifying enzymes dynamics would deepen our understanding on their respective toxicities and carcinogenicities.

MeSH Terms
Animals Arsenic/toxicity Carcinogens/toxicity Chromium/toxicity Dioxygenases/metabolism Epigenomics Humans Nickel/toxicity
Chemicals
Carcinogens Chromium Nickel Dioxygenases Arsenic
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Chervona Yana
New York University School of Medicine, Nelson Institute of Environmental Medicine, 57 Old Forge Road, NY 10987, USA.
Arita Adriana
Costa Max
References (54)
54 references, click to expand
  1. Inorganic arsenic and human prostate cancer.
    Environ Health Perspect. 2008 Feb;116(2):158-64 PMID: 18288312
  2. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens.
    Mol Cell Biol. 1995 May;15(5):2547-57 PMID: 7537850
  3. JmjC-domain-containing proteins and histone demethylation.
    Nat Rev Genet. 2006 Sep;7(9):715-27 PMID: 16983801
  4. Global levels of histone modifications in peripheral blood mononuclear cells of subjects with exposure to nickel.
    Environ Health Perspect. 2012 Feb;120(2):198-203 PMID: 22024396
  5. Cadmium exposure in the population: from health risks to strategies of prevention.
    Biometals. 2010 Oct;23(5):769-82 PMID: 20517707
  6. Perspectives on the mechanism of nickel carcinogenesis.
    Adv Inorg Biochem. 1984;6:285-309 PMID: 6398965
  7. Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing.
    Mol Cell Biol. 2006 May;26(10):3728-37 PMID: 16648469
  8. Nickel carcinogenesis.
    Mutat Res. 2003 Dec 10;533(1-2):67-97 PMID: 14643413
  9. The reduction of chromate is a prerequisite of chromium binding to cell nuclei.
    Carcinogenesis. 1991 Jun;12(6):1143-4 PMID: 2044197
  10. Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells.
    Cancer Res. 1982 Jul;42(7):2729-35 PMID: 7083163
  11. Health effects of arsenic and chromium in drinking water: recent human findings.
    Annu Rev Public Health. 2009;30:107-22 PMID: 19012537
  12. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans.
    Environ Geochem Health. 2009 Apr;31 Suppl 1:189-200 PMID: 19190988
  13. Lung cancer mortality in the German chromate industry, 1958 to 1998.
    J Occup Environ Med. 2006 Apr;48(4):426-33 PMID: 16607199
  14. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states.
    Carcinogenesis. 2008 Jan;29(1):2-8 PMID: 17916902
  15. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects.
    Crit Rev Toxicol. 2009;39(4):271-98 PMID: 19235533
  16. Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines at the xanthine-guanine phosphoribosyl transferase locus.
    Mutat Res. 1993 Jun;300(1):63-72 PMID: 7683771
  17. Cancers of the lung and nasal sinuses in nickel workers.
    Br J Cancer. 1970 Dec;24(4):623-32 PMID: 5503591
  18. Iron- and 2-oxoglutarate-dependent dioxygenases: an emerging group of molecular targets for nickel toxicity and carcinogenicity.
    Biometals. 2009 Feb;22(1):191-6 PMID: 19096759
  19. Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
    Am J Clin Pathol. 2010 Dec;134(6):873-9 PMID: 21088149
  20. Soluble nickel interferes with cellular iron homeostasis.
    Mol Cell Biochem. 2005 Nov;279(1-2):157-62 PMID: 16283525
  21. Arsenite alters global histone H3 methylation.
    Carcinogenesis. 2008 Sep;29(9):1831-6 PMID: 18321869
  22. Lung cancer among workers in chromium chemical production.
    Am J Ind Med. 2000 Aug;38(2):115-26 PMID: 10893504
  23. X-ray absorption spectroscopy structural investigation of early intermediates in the mechanism of DNA repair by human ABH2.
    Biochemistry. 2011 Jun 7;50(22):5067-76 PMID: 21510633
  24. Toxicity and carcinogenicity of Cr(VI) in animal models and humans.
    Crit Rev Toxicol. 1997 Sep;27(5):431-42 PMID: 9347224
  25. Cytotoxic, mutagenic and clastogenic effects of industrial chromium compounds.
    Carcinogenesis. 1982;3(11):1331-8 PMID: 6758977
  26. Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium.
    Contact Dermatitis. 2003 Jul;49(1):1-7 PMID: 14641113
  27. Fluorescent tracking of nickel ions in human cultured cells.
    Toxicol Appl Pharmacol. 2007 Feb 15;219(1):18-23 PMID: 17239912
  28. Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment.
    Risk Anal. 2004 Oct;24(5):1099-108 PMID: 15563281
  29. Cytoplasmic dissolution of phagocytized crystalline nickel sulfide particles: a prerequisite for nuclear uptake of nickel.
    J Toxicol Environ Health. 1982 Apr;9(4):663-76 PMID: 7108981
  30. Toxicity and carcinogenicity of chromium compounds in humans.
    Crit Rev Toxicol. 2006 Feb;36(2):155-63 PMID: 16736941
  31. Carcinogenesis bioassays of nickel oxides and nickel-copper oxides by intramuscular administration to Fischer-344 rats.
    Res Commun Chem Pathol Pharmacol. 1990 Oct;70(1):103-13 PMID: 2263758
  32. Uptake and reduction of Cr(VI) to Cr(III) by mesquite (Prosopis spp.): chromate-plant interaction in hydroponics and solid media studied using XAS.
    Environ Sci Technol. 2003 May 1;37(9):1859-64 PMID: 12775058
  33. Comparison of gene expression profiles in chromate transformed BEAS-2B cells.
    PLoS One. 2011 Mar 18;6(3):e17982 PMID: 21437242
  34. Structural studies on 2-oxoglutarate oxygenases and related double-stranded beta-helix fold proteins.
    J Inorg Biochem. 2006 Apr;100(4):644-69 PMID: 16513174
  35. Factors influencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems.
    Toxicol Appl Pharmacol. 1981 Sep 15;60(2):313-23 PMID: 7281191
  36. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.
    Virchows Arch. 2011 Aug;459(2):193-200 PMID: 21691815
  37. The phagocytosis and transforming activity of crystalline metal sulfide particles are related to their negative surface charge.
    Carcinogenesis. 1982;3(2):175-80 PMID: 7067046
  38. Mechanism of arsenic carcinogenesis: an integrated approach.
    Mutat Res. 2003 Dec 10;533(1-2):37-65 PMID: 14643412
  39. Soluble nickel inhibits HIF-prolyl-hydroxylases creating persistent hypoxic signaling in A549 cells.
    Mol Carcinog. 2006 Jul;45(7):479-89 PMID: 16649251
  40. Effects of nickel, chromate, and arsenite on histone 3 lysine methylation.
    Toxicol Appl Pharmacol. 2009 Apr 1;236(1):78-84 PMID: 19371620
  41. Cancer risks from arsenic in drinking water.
    Environ Health Perspect. 1992 Jul;97:259-67 PMID: 1396465
  42. Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers.
    J Biol Chem. 2010 Mar 5;285(10):7374-83 PMID: 20042601
  43. Does arsenic exposure increase the risk for liver cancer?
    J Toxicol Environ Health A. 2004 Oct 8;67(19):1491-500 PMID: 15371225
  44. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate.
    Carcinogenesis. 1995 Apr;16(4):907-13 PMID: 7728973
  45. Cancer epigenomics: DNA methylomes and histone-modification maps.
    Nat Rev Genet. 2007 Apr;8(4):286-98 PMID: 17339880
  46. Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion.
    J Cell Sci. 2011 Apr 1;124(Pt 7):1077-87 PMID: 21363891
  47. The complex language of chromatin regulation during transcription.
    Nature. 2007 May 24;447(7143):407-12 PMID: 17522673
  48. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group.
    Biochemistry. 1996 Jun 4;35(22):7275-82 PMID: 8679557
  49. Dimethylation of histone H3 lysine 9 is a critical mark for DNA methylation and gene silencing in Arabidopsis thaliana.
    Chromosoma. 2004 Mar;112(6):308-15 PMID: 15014946
  50. Effects of nickel treatment on H3K4 trimethylation and gene expression.
    PLoS One. 2011 Mar 24;6(3):e17728 PMID: 21455298
  51. Carcinogenic activity of particulate nickel compounds is proportional to their cellular uptake.
    Science. 1980 Jul 25;209(4455):515-7 PMID: 7394519
  52. Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium.
    Toxicol Appl Pharmacol. 2009 Jun 15;237(3):258-66 PMID: 19376149
  53. Hypoxia-inducible factor-1 (HIF-1).
    Mol Pharmacol. 2006 Nov;70(5):1469-80 PMID: 16887934
  54. Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells.
    Carcinogenesis. 2010 Dec;31(12):2136-44 PMID: 20881000
Article Info
Journal
Metallomics : integrated biometal science
Abbr.
Metallomics
ISSN
1756-591X
Published
2012-07-00
Epub
2012-00-03
Pages
619-27
Language
English
Region
England
NLM ID
101478346
PMCID
PMC3687545
Subset
IM
Grants
NCI NIH HHS · P30 CA016087 · United States
NIEHS NIH HHS · R01 ES014454 · United States
NIEHS NIH HHS · R01 ES005512 · United States
NIEHS NIH HHS · P30 ES000260 · United States
NIEHS NIH HHS · P42 ES010349 · United States
NIEHS NIH HHS · P42 ES010344 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com